Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
02/17/1994 | WO1994003431A1 Isoserine derivatives and their use as leukotriene antagonists |
02/17/1994 | WO1994003202A1 Interleukin-4 stimulated t lymphocyte cell death |
02/17/1994 | WO1994003178A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
02/17/1994 | WO1994003170A1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
02/17/1994 | WO1994000555A3 Compositions for the inhibition of protein hormone formation and uses thereof |
02/17/1994 | WO1993018054A3 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
02/17/1994 | CA2141557A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
02/17/1994 | CA2134565A1 Isoserine derivatives and their use as leukotriene antagonists |
02/16/1994 | EP0582916A1 N-methansulfonyl-2-(3-isobutyl-3-(quinol-2-yl-methoxy)-phenyl)-2-cycloalkylacetamides, process for their preparation and their pharmaceutical use |
02/16/1994 | EP0582908A1 2-Substituted guinolylmethoxy-phenylacetic acid derivatives, process for their preparation and their pharmaceutical use |
02/16/1994 | EP0582690A1 Novel immunosuppressant agent from streptomyces braegensis |
02/16/1994 | EP0582672A1 Methods to detect and treat diseases caused by bacterial allergens |
02/16/1994 | EP0582630A1 N?6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body |
02/16/1994 | EP0449897B1 A pure factor i protein and a process for producing said protein |
02/15/1994 | US5286858 Optically active thienotriazolodiazepine compounds |
02/15/1994 | US5286731 Method of treating immunoinflammatory bowel disease |
02/15/1994 | US5286730 Administering rapamycins for skin disorders |
02/15/1994 | CA1327050C Phenolic thioethers, sulfoxides, and disulfides as inhibitors of 5-lipoxygenase |
02/15/1994 | CA1327047C Complexes of tellurium and selenium derivatives |
02/15/1994 | CA1327046C Tellurium and selenium compounds for the induction of in vivo and in vitro production of cytokines |
02/13/1994 | CA2103600A1 Isobutyl-substituted methanesulphonyl- quinolyl-methoxyphenyl-cycloalkylacetamides |
02/12/1994 | CA2103521A1 Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives |
02/09/1994 | EP0582455A1 Benzoxazinones as inhibitors of HIV reverse transcriptase |
02/09/1994 | EP0581967A1 Protein with novel pharmacological characteristic |
02/09/1994 | EP0581959A1 Use of macrolide compounds for eye diseases |
02/09/1994 | EP0581916A1 Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom |
02/09/1994 | EP0581856A1 Method of preventing nmda receptor complex-mediated neuronal damage |
02/09/1994 | EP0581848A1 Closed sense and antisense oligonucleotides and uses thereof |
02/09/1994 | EP0581803A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
02/09/1994 | EP0581777A1 Stereoselective preparation of substituted piperidines |
02/09/1994 | EP0343227B1 Selective removal of immune complexes |
02/08/1994 | US5284935 Major histocompatibility complex |
02/08/1994 | US5284868 Naphthopyran derivatives; for autoimmune diseases, cancer |
02/08/1994 | US5284656 Pulmonary administration of granulocyte colony stimulating factor |
02/08/1994 | CA1326940C Purification of lfa-3 |
02/08/1994 | CA1326853C Ethynylheteroaromatic acids having retinoic acid-like activity |
02/03/1994 | WO1994002506A1 Peptide compounds |
02/03/1994 | WO1994002485A1 Rapamycin derivatives |
02/03/1994 | WO1994002459A1 Indolinyl n-hydrozyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors |
02/03/1994 | WO1994002448A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
02/03/1994 | WO1994002447A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
02/03/1994 | WO1994002446A1 Natural amino acid derivatives as metalloproteinase inhibitors |
02/03/1994 | WO1994002445A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression |
02/03/1994 | WO1994002158A1 Drug, particularly an immunomodulator, containing non-fructifying, non-photosynthetic filamentous bacteria envelopes or fractions thereof, and preparation thereof |
02/03/1994 | WO1994002155A1 Antiviral combinations |
02/03/1994 | WO1994002154A1 Antiviral combinations |
02/03/1994 | WO1994002146A1 Flavopereirine-based pharmaceutical composition and use thereof for treating hiv |
02/03/1994 | WO1994002137A1 Rapamycin derivatives |
02/03/1994 | WO1994002136A1 Rapamycin derivatives |
02/03/1994 | WO1994002068A1 System of drug delivery to the lymphatic tissues |
02/03/1994 | WO1993021321A3 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA) |
02/03/1994 | CA2141214A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
02/03/1994 | CA2140931A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune disease and tumour progression |
02/03/1994 | CA2140237A1 Antiviral combinations |
02/02/1994 | EP0580829A1 Bacterial protein extract, process for preparing the same and pharmaceutical composition containing said extract |
02/02/1994 | EP0580774A1 Vitamin d derivatives comprising a lateral chain expoxide group |
02/02/1994 | EP0580738A1 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity. |
02/02/1994 | EP0580609A1 Pharmaceutical xanthone derivatives |
02/02/1994 | EP0363491B1 Bacterial preparation for prophylaxis and treatment of inflammatory processes and allergic diseases |
02/01/1994 | US5283361 N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as lipoxygenase inhibitors |
02/01/1994 | US5283268 Compounds for the treatment of inflammation and allergy |
02/01/1994 | US5283245 Antiinflammatory agent, antiallergens |
02/01/1994 | US5283243 Anti-inflammatory, anti-allergic, hypotensive and vasodilating agents |
02/01/1994 | US5283058 Preventing the cytolysis of lymphocyte by alternating the antigen on donor's cell |
01/26/1994 | EP0580541A1 New piperidine derivatives of benzimidazole as antihistanminic and antiallergic agents |
01/26/1994 | EP0580502A1 3-(Hydroxybenzylidenyl)-indoline-2-ones and pharmaceutical compositions containing them |
01/26/1994 | EP0580402A2 Aminediol protease inhibitors |
01/26/1994 | EP0580074A1 Stable preparation containing azelastine hydrochloride |
01/26/1994 | EP0579939A1 Phospholipid derivatives |
01/26/1994 | EP0579747A1 Method of modulating mammalian t-cell response |
01/26/1994 | EP0579731A1 Disubstituted naphthalenes |
01/26/1994 | EP0579695A1 Reissert compounds as anti-hiv agents |
01/26/1994 | EP0428573B1 Method and compositions for the treatment and prevention of septic shock |
01/26/1994 | EP0423301B1 Synthetic peptides of the conjugate of ubiquitine and histone h2a |
01/25/1994 | US5281702 Di-N-deacetyl-lysogangliosides |
01/25/1994 | CA1326450C Modulation of aids virus-related events by double stranded rnas (dsrnas) |
01/22/1994 | CA2100944A1 3-(hydroxybenzylidenyl)-indoline-2-ones, their preparation and the pharmaceutical compositions containing them |
01/21/1994 | CA2100894A1 Aminediol protease inhibitors |
01/20/1994 | WO1994001552A1 Target antigens of transmission blocking antibodies for malaria parsites |
01/20/1994 | WO1994001547A2 A method for generation of antibodies to cell surface molecules |
01/20/1994 | WO1994001534A1 Hematopoietic facilitatory cells and their uses |
01/20/1994 | WO1994001533A1 Deletion mutants as vaccines for cholera |
01/20/1994 | WO1994001430A1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders |
01/20/1994 | WO1994001413A1 Boronated compounds |
01/20/1994 | WO1994001406A1 Contrast agents for mr diagnosis |
01/20/1994 | WO1994001398A1 Vitamin d analogues |
01/20/1994 | WO1994001138A1 Covalent polar lipid-peptide conjugates for biological targeting |
01/20/1994 | WO1994001131A1 Transvascular and intracellular delivery of lipidized proteins |
01/20/1994 | CA2140034A1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders |
01/20/1994 | CA2138646A1 Target antigens of transmission blocking antibodies for malaria parasites |
01/20/1994 | CA2131631A1 Vitamin d analogues |
01/20/1994 | CA2120954A1 Allergenic proteins and peptides from japanese cedar pollen |
01/20/1994 | CA2118586A1 Transvascular and intracellular delivery of lipidized proteins |
01/19/1994 | EP0579496A1 4-Aminoquinazoline derivatives, and their use as medicine |
01/19/1994 | EP0579412A1 1,2,4-trioxygenated benzene derivatives useful as a leukotriene antagonists |
01/19/1994 | EP0579304A1 Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
01/19/1994 | EP0579196A1 Glycolipid derivatives |
01/19/1994 | EP0579066A2 N-substituted anilines |
01/19/1994 | EP0578932A2 IL-2 receptor gamma chain molecule |
01/19/1994 | EP0578819A1 Icam-related protein |